Exacerbations of Graves' disease after unilateral adrenalectomy for Cushing's syndrome

被引:7
作者
Arikan, E [1 ]
Guldiken, S [1 ]
Altun, BU [1 ]
Kara, M [1 ]
Tugrul, A [1 ]
机构
[1] Trakya Univ, Tip Fakultesi, Endokrinol BD, TR-22030 Edirne, Turkey
关键词
Graves' disease; Cushing's syndrome; autoimmunity;
D O I
10.1007/BF03347482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cushing's syndrome is characterized by endogenously increased production of glucocorticoids. The activity of immune system is regulated mainly by two systems in the body. Glucocorticoids and NF-kappaB counteract the effects of each other on the immune system. It has been reported that immune response is exaggerated after the amelioration of Cushing's syndrome. We report a rare case of exacerbation of Graves' disease after unilateral adrenalectomy for Cusing's syndrome. A 50-yr-obese woman with hypertension, dyslipidemia, impaired glucose tolerance and insulin resistance was admitted to outpatients clinic of endocrinology. The results of evaluation of glucocorticoids metabolism and adrenal magnetic resonance imaging revealed the Cusing's syndrome. We also assessed thyroid function tests because of the diagnosis of golter and thyroid hormone replacement in her medical history, and the presence of exophthalmia and tachycardia in examination. Althoug TSH level was detected at the lower border of normal range, free T-4 and free T-3 were in normal range and autoantibody of thyroidal peroxidase and thyroglobulin was higer than normal reference range. An operation was performed and a mass was removed from her left adrenal gland. The pathologic examination confirmed adrenal adenoma. She was re-admitted to the outpatient clinic 9 months after with complaints of palpitation, malaise and weight loss. Tests carried out to determine the thyroid function revealed Graves' disease. We prescribed propylthiouracil and P-blocker treatment. (C) 2004, Editrice Kurtis.
引用
收藏
页码:574 / 576
页数:3
相关论文
共 14 条
[1]   TSH SECRETION IN CUSHINGS-SYNDROME - RELATION TO GLUCOCORTICOID EXCESS, DIABETES, GOITER, AND THE SICK EUTHYROID SYNDROME [J].
BENKER, G ;
RAIDA, M ;
OLBRICHT, T ;
WAGNER, R ;
REINHARDT, W ;
REINWEIN, D .
CLINICAL ENDOCRINOLOGY, 1990, 33 (06) :777-786
[2]   Cushing's syndrome [J].
Boscaro, M ;
Barzon, L ;
Fallo, F ;
Sonino, N .
LANCET, 2001, 357 (9258) :783-791
[3]   THE ROLE OF GLUCOCORTICOIDS IN THE REGULATION OF THYROTROPIN [J].
BRABANT, A ;
BRABANT, G ;
SCHUERMEYER, T ;
RANFT, U ;
SCHMIDT, FW ;
HESCH, RD ;
VONZURMUHLEN, A .
ACTA ENDOCRINOLOGICA, 1989, 121 (01) :95-100
[4]  
CHIOVALO L, 2001, ENDOCRINOLOGY, P1422
[5]   Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease [J].
Colao, A ;
Pivonello, R ;
Faggiano, A ;
Filippella, M ;
Ferone, D ;
Di Somma, C ;
Cerbone, G ;
Marzullo, P ;
Fenzi, G ;
Lombardi, G .
CLINICAL ENDOCRINOLOGY, 2000, 53 (01) :13-19
[6]   Immune regulation in Cushing's syndrome: Relationship to hypothalamic-pituitary-adrenal axis hormones [J].
Kronfol, Z ;
Starkman, M ;
Schteingart, DE ;
Singh, V ;
Zhang, Q ;
Hill, E .
PSYCHONEUROENDOCRINOLOGY, 1996, 21 (07) :599-608
[7]   Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways [J].
McKay, LI ;
Cidlowski, JA .
ENDOCRINE REVIEWS, 1999, 20 (04) :435-459
[8]   Transient graves disease developing after surgery for Cushing disease [J].
Morita, H ;
Isaji, M ;
Mune, T ;
Daido, H ;
Isomura, Y ;
Sarui, H ;
Tanahashi, T ;
Takeda, N .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (03) :162-165
[9]  
Muzulu SI, 1998, BRIT J RHEUMATOL, V37, P804
[10]   Systemic lupus erythematosus after pituitary adenomectomy in a patient with Cushing's disease [J].
Noguchi, Y ;
Tamai, H ;
Fujisawa, K ;
Nagano, J ;
Mukuta, T ;
Komaki, G ;
Masubayashi, S ;
Kubo, C ;
Torisu, M ;
Nakagaki, H ;
Imayama, S .
CLINICAL ENDOCRINOLOGY, 1998, 48 (05) :670-672